Multi-nuclear MRS and 19F MRI of 19F-labelled and 10B-enriched p-boronophenylalanine-fructose complex to optimize boron neutron capture therapy: Phantom studies at high magnetic fields

Physics in Medicine and Biology

Volumn 51, Issue 12, 2006, Pages 3141-3154

  Porcari, Paola ^a,b   Capuani, Silvia ^a,b   Campanella, Renzo ^c   La Bella, Angela ^d   Migneco, Luisa Maria ^d   Maraviglia, Bruno ^a,b,e  

^a UNIVERSITÀ DI ROMA LA SAPIENZA   (Italy)

^b MUSEO STORICO DELLA FISICA E CENTRO STUDI E RICERCHE ENRICO FERMI   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; BORON; MAGNETIC FIELD EFFECTS; MAGNETIC RESONANCE SPECTROSCOPY; MEDICAL IMAGING; OPTIMIZATION; RADIOTHERAPY;

BORON NEUTRON CAPTURE THERAPY; PHANTOM; REACTION YIELD OPTIMIZATION; SPATIAL DISTRIBUTION MAPPING;

MAGNETIC RESONANCE IMAGING;

4 BORONOPHENYLALANINE B 10; FLUORINE;

AQUEOUS SOLUTION; ARTICLE; BLOOD; CARBON NUCLEAR MAGNETIC RESONANCE; IMAGE ANALYSIS; IMAGE QUALITY; IN VITRO STUDY; MAGNETIC FIELD; NEUTRON CAPTURE THERAPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; REACTION ANALYSIS;

ANIMALS; BORON; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; FEASIBILITY STUDIES; FRUCTOSE; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MAGNETICS; PHANTOMS, IMAGING; RADIOPHARMACEUTICALS; RADIOTHERAPY, COMPUTER-ASSISTED; RATS;

EID: 33745089021     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/51/12/010     Document Type: Article

References (42)

1. Abragam A 1982 Principles of Nuclear Magnetism (Oxford: Clarendon)
2. Barth R F and Soloway A H 1997 Boron neutron capture therapy of brain tumors-current status and future prospects J. Neurooncol. 33 3-18
3. Barth R F, Soloway A H, Fairchild R G and Brugger R M 1992 Boron neutron capture therapy for cancer. Realities and prospects Cancer 70 2995-3007
4. Barth R F, Soloway A H, Fairchild R G and Brugger R M 1996 Boron neutron capture therapy of brain tumors: past history, current status, and future potential Cancer Invest. 14 534-50
5. Barth R F, Soloway A H, Goodman J H, Gahbauer R A, Gupta N, Blue T E, Yang W and Tjarks W 1999 Boron neutron capture therapy of brain tumors: an emerging therapeutic modality Neurosurgery 44 433-51
6. 11B NMR NMR Biomed. 18 74-82
7. 10B MRI Magn. Reson. Med. 46 13-7
8. Bendel P, Margalit R, Koudinova N and Salomon Y 2005a Noninvasive quantitative in vivo mapping and metabolism of boronophenylalanine (BPA) by nuclear magnetic resonance (NMR) spectroscopy and imaging Radiat. Res. 164 680-7
9. 1H MRS and MRSI methods for the in vivo detection of boronophenylalanine Magn. Reson. Med. 53 1166-71
10. 10B NMR Med. Phys. 28 178-83
11. 10B double resonance Magn. Reson. Med. 32 170-4
12. 19F-BPA in a mouse melanoma model Advances in Neutron Capture Therapy (Zurich, Switzerland, 4-7 Sept. 1996) (Biology and Chemistry vol 2) ed B Larsson, J Crawford and R Weinreich (Amsterdam: Elsevier Science) pp 632-9
13. Bergenheim A T, Capala J, Roslin M and Henriksson R 2005 Distribution and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study J. Neurooncol. 71 287-93
14. 11B MRI Magn. Reson. Med. 34 48-56
15. Bulte J W 2005 Hot spot MRI emerges from the background Nat. Biotechnol. 23 945-6
16. Campanella R, Capuani S, Fasano F and Maraviglia B 2002 Double resonance NMR imaging of BSH Research and Development in Neutron Capture Therapy (Essen, Germany, 8-13 Sept.) ed W Sauerwein, R Moss and A Witting (Bologna: Monduzzi Editore) pp 963-5
17. Capala J et al 2003 Boron neutron capture therapy (BNCT) for glioblastoma multiforme: clinical studies in Sweden J. Neurooncol. 62 135-44
18. Chanda M D, Capala J, Coderre J A, Elowitz E H, Iwai J, Joel D D, Liu H B, Wielopolski L and Chanana A D 1998 Boron neutron capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory Int. J. Radiat. Oncol. Biol. Phys. 40 829-34
19. Chandra S, Kabalka G W, Lorey D R I I, Smith D R and Coderre J A 2002 Imaging of fluorine and boron from fluorinated boronophenylalanine in the same cell at organelle resolution by correlative ion microscopy and confocal laser scanning microscopy Clin. Cancer. Res. 8 2675-83
20. Coderre J A et al 1998 Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity Radiat. Res. 149 163-70
21. Coderre J A, Elowitz E H, Chanda M D, Bergland R, Capala J, Joel D D, Liu H B, Statkin D N and Chanana A D 1997 Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and the epithermal neutrons: trial design and early clinical results J. Neurooncol. 33 141-52
22. Coderre J A and Morris G M 1999 The radiation biology of boron neutron capture therapy Radiat. Res. 151 1-18
23. De Luca F, Campanella R, Bifone A and Maraviglia B 1991 Boron-10 double resonance spatial NMR detection Chem. Phys. Lett. 186 303-6
24. Elowitz E H, Bergland R M, Coderre J A, Joel D D, Chandha M and Chanana A D 1998 Biodistribution of boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy Neurosurgery 42 463-9
25. 10B-para-boronophenylalanine in thermal neutron capture therapy of malignant melanoma: in vitro radiobiological evaluation J. Invest. Dermatol. 78 215-18
26. Imahori Y, Ueda S, Ohmori Y, Kusuki T, Ono K, Fujii R and Ido T 1998 Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma J. Nucl. Med. 39 325-33
27. Joensuu H et al 2003 Neutron capture therapy of brain tumors: clinical trials at the Finnish facility using boronophenylalanine J. Neurooncol. 62 123-34
28. Kabalka G W, Davis P and Bendel P 1988 Boron-11 MRI and MRS of intact animals infused with a boron-neutron-capture-agent Magn. Reson. Med. 8 231-7
29. Kabalka G W, Nichols T L, Smith G T, Miller L F, Khan M K and Busse P M 2003 The use of positron emission tomography to develop boron neutron capture therapy treatment plans for metastatic malignant melanoma J. Neurooncol. 62 187-95
30. Kabalka G W, Reddy N K, Wang L and Malladi R R 2000 Synthesis of 4-borono-2-fluorophenylalanine Org. Prep. Proced. Int. 32 290-3
31. Kabalka G W, Tang C and Bendel P 1997 The role of boron MRI in boron neutron capture therapy J. Neurooncol. 33 153-61
32. Laakso J, Kulvik M, Ruokonen I, Vahatalo J, Zilliacus R, Farkkila M and Kallio M 2001 Atomic emission method for total boron in blood during neutron capture therapy Clin. Chem. 47 1796-803
33. Panov V, Salomon Y, Kabalka G W and Bendel P 2000 Uptake and washout of borocaptate sodium and borono-phenylalanine in cultured melanoma cells: a multi-nuclear NMR study Radiat. Res. 154 104-12
34. 18F]fluoro-L-phenylalanine-fructose complex for use in timing boron neutron capture therapy (BNCT) J. Lab. Compd. Radiopharm. 33 599-600
35. 10B in blood after BPA-fructose complex infusion Phys. Med. Biol. 47 737-45
36. 10B concentration after BPA-fructose complex infusion in patient during epithermal neutron irradiation in BNCT Int. J. Radiat. Oncol. Biol. Phys. 48 1145-54
37. 13C NMR evidence for β-D-fructofuranose 2,3,6,-(p-phenylalnylorthoboronate) structure J. Pharm. Sci. 89 215-22
38. 10B from boronophenylalanine in a brain tumor model for boron neutron capture therapy Cancer Res. 56 4302-6
39. Snyder H R, Reedy A J and Lennarz W 1958 Synthesis of aromatic boronic acids. Aldehydo boronic acids and a boronic acids analog of tyrosine J. Am. Chem. Soc. 80 835-8
40. 18F-fluoro-L- phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model J. Nucl. Med. 45 302-8
41. Yoshino K, Suzuki A, Mori Y, Kakiana H, Honda C, Mishima Y, Kobayashi T and Kanda K 1989 Improvement of solubility of p-boronophenylalanine by complex formation with monosaccharides Strahlenther Onkol. 165 127-9
42. Zuo C S, Prasad P V, Busse P, Tang L and Zamenhof R G 1999 Proton nuclear magnetic resonance measurement of p-boronophenylalanine (BPA): a therapeutic agent for boron neutron capture therapy Med. Phys. 26 1230-6